The NeuroNext Fellow Award provides 1 years of support for early-career research faculty from the Department of Neurology and the National Institutes of Health to build clinical and translational research skills and competencies under the guidance of the NeuroNext Executive Leadership team, for Phase 2 or Phase 3 trials. Fellows will receive up to $20,000/year to support educational, time and other research needs.
The Network for Excellence in Neuroscience Clinical Trials, or NeuroNEXT, was created to conduct studies of treatments for neurological diseases through partnerships with academia, private foundations, and industry. Funded by the National Institutes of Health's National Institute of Neurological Disorders and Stroke (NINDS), NeuroNEXT was designed to:
- Increase efficiency of clinical trials
- Expand the capability of NINDS to test promising new therapies
- Respond quickly as opportunities arise to test promising new treatments for people with neurological disorders
Working with NeuroNEXT is a cooperative venture between NINDS, the Network coordinating centers, and the academic, small business, or industry collaborator. The Network provides a robust, standardized, and accessible infrastructure to facilitate the rapid development and implementation of protocols in neurological disorders, in both adult and pediatric populations. The network includes clinical sites, a Clinical Coordinating Center, and a Data Coordinating Center.
Learn more about NeuroNEXT.